BSMed
ActiveSummary
BSMed has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€4,290) and a net result of -€5,314. Equity has been shrinking by about 173% per year since 2023. The computed 12-month bankruptcy probability is 1.5% (low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 20-07-2022 Normal situation
- Activity
- “La société pourra faire toutes opérations civiles d’achat, de vente, de transformation, d’aménagement, de…” (deed in French)From the articles, 9 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.337.558.359 7322 Bernissart, since 20-07-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 23-11-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.5%
- Gross margin
- -€1,924
- ▼ 4.2%
- Loss
- €5,314
- ▼ 44.3%
- Equity
- -€4,290
- Total assets
- €260,022
- ▲ 2.0%
- Negative equity on 31-12-2025
Score breakdownraises riskCapped at 59: negative equityLiquidity: current ratio 0.00, cash €33, halvedFounded in 2022lowers riskSize: total assets €260,022No main activity registeredShow the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 15% of them on solvency, 2% on liquidity, 15% on profitability and 0% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 3 accounts on average 25 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
Financials
Financials · financial year 2025, micro format
Annual accounts 2025 filed on 29-06-2026 at the NBB all 3 filings
Every figure per financial year
The operating result for 2025 is a loss of €5,215, smaller than the loss of €9,495 in 2024.
Turnover and EBIT margin are not published. The micro format does not require them.
Investments
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Tangible fixed assets | €257,392 | €24,244 | €8,169 |
| Depreciation and write-downs of the year | €20,084 | €7,252 | €2,479 |
Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €20,084 | €7,252 | €2,479 | ▼ 65.8% |
| Other operating charges640/8 | €348 | €396 | €811 | ▲ 105% |
| Gross operating margin9900 | -€7,943 | -€1,847 | -€1,924 | ▼ 4.2% |
| Operating profit (loss)9901 | -€28,375 | -€9,495 | -€5,215 | ▲ 45.1% |
| Financial charges65/66B | €57 | €49 | €99 | ▲ 105% |
| Recurring financial charges65 | €57 | €49 | €99 | ▲ 105% |
| Profit (loss) for the period before taxes9903 | -€28,432 | -€9,544 | -€5,314 | ▲ 44.3% |
| Profit (loss) for the period9904 | -€28,432 | -€9,544 | -€5,314 | ▲ 44.3% |
| Profit (loss) for the period to be appropriated9905 | -€28,432 | -€9,544 | -€5,314 | ▲ 44.3% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €237,891 | €254,836 | €260,022 | ▲ 2.0% |
| Fixed assets21/28 | €237,308 | €254,299 | €259,989 | ▲ 2.2% |
| Tangible fixed assets22/27 | €237,308 | €254,299 | €259,989 | ▲ 2.2% |
| Land and buildings22 | €237,308 | €254,299 | €259,989 | ▲ 2.2% |
| Current assets29/58 | €583 | €537 | €33 | ▼ 93.8% |
| Cash at bank and in hand54/58 | €583 | €537 | €33 | ▼ 93.8% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €237,891 | €254,836 | €260,022 | ▲ 2.0% |
| Equity10/15 | €10,568 | €1,024 | -€4,290 | - |
| Contributions10/11 | €39,000 | €39,000 | €39,000 | = |
| Profit (loss) carried forward14 | -€28,432 | -€37,976 | -€43,290 | ▼ 14.0% |
| Amounts payable17/49 | €227,323 | €253,812 | €264,312 | ▲ 4.1% |
| Amounts payable within one year42/48 | €227,323 | €253,812 | €264,312 | ▲ 4.1% |
| Other amounts payable47/48 | €227,323 | €253,812 | €264,312 | ▲ 4.1% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | -€28,432 | -€9,544 | -€5,314 | ▲ 44.3% |
| + Depreciation and write-downs630 | €20,084 | €7,252 | €2,479 | ▼ 65.8% |
| Operating cash flow (approximation) | -€8,347 | -€2,292 | -€2,835 | ▼ 23.7% |
| Investment in fixed assets (approximation) | - | -€24,244 | -€8,169 | ▲ 66.3% |
| Change in cash | - | -€46 | -€504 | ▼ 991% |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 1,555 companies had the same profile as BSMed has now. Two years later, 91.6% were still going and 4.6% had gone bankrupt.
- Micro
- 2 to 5 years old
- negative equity
- a small loss
Another 0.2% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of BSMed itself: 1.5% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,555 companies, not a prediction for BSMed. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Board & ownership
Directors
Owners and capital
Shareholders
- MARCHAND Guillaume Max Louis 130 shares (33.3%) · €13,000
- STOCKHEM Amandine 130 shares (33.3%) · €13,000
- BONACORSI Eléna 130 shares (33.3%) · €13,000
Capital transactions
- 25-07-2022 Incorporation · €39,000 · 390 shares
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| MARCHAND Guillaume Max Louis |
|
| BONACORSI Eléna |
|
| STOCKHEM Amandine |
|
Articles of association
- Share issue ruleThe articles set how and by whom new shares are issued.
- “Agrément de la moitié des actionnaires possédant trois quarts des actions, droit de préférence en numéraire”
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Articles of association, deed of 25-07-2022 (in French)
Network & group
BSMed shares no director with another company.
Connections & network
1 current directorThe network starts from the directors of BSMed. Every other company they run is a node.
Timeline
Acts, filings and financial milestones
02-02
Gazette deed
Resignations: STOCKHEM Amandine (director) and BONACORSI Eléna (director)3 points ▸
- General meeting, 01-10-2022
- Director resignation, STOCKHEM Amandine
- Director resignation, BONACORSI Eléna
25-07
Gazette deed
IncorporationStarting capital €39,000 · Appointments: BONACORSI Eléna, STOCKHEM Amandine and MARCHAND Guillaume Max Louis · Founder22 points ▸
- Incorporation, 14-07-2022
- Founder, MARCHAND Guillaume Max Louis (fondateur et souscripteur)
- Founder, STOCKHEM Amandine (fondateur et souscripteur)
- Founder, BONACORSI Eléna (fondateur et souscripteur)
- Founding capital, €39,000
- Other provision, 27-06-2022
- Other provision, “responsabilité des fondateurs, faillite dans les trois ans de la constitution” (deed in French)
- Bank account, 39000, EUR
- Other provision, “attestation de dépôt”, 39000 (deed in French)
- Other provision, “avertissements du notaire” (deed in French)
- Other provision, “dénomination, professions réglementées, formalités, modification et dommages-intérêts à demande de tout intéressé” (deed in French)
- Other provision, “nominations reportées, in fine des présentes” (deed in French)
- The act holds 10 more points.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordRegistered office and establishments
Activities
9 activities
- La société pourra faire toutes opérations civiles d’achat, de vente, de transformation, d’aménagement, de conclusion de baux commerciaux et/ou civils, de sous-location, d’échange et de vente de tous immeubles.
- La société pourra également contracter ou consentir tout prêt quelconque.
- La société pourra d'une façon générale, accomplir, soit seule, soit avec d’autres, toutes opérations généralement quelconques, financières, mobilières ou immobilières se rapportant directement ou indirectement à son objet social ou qui seraient de nature à en faciliter directement ou indirectement la réalisation.
- Elle pourra également construire, acquérir la pleine propriété ou des droits réels, louer ou sous-louer, prendre en location ou en sous-location, tous immeubles dans le but d’y exercer des activités qui relèvent de l’objet social, d’y établir son siège social ou administratif, ou d’y loger ses dirigeants ou les membres de leur famille.
- Elle dispose, d’une manière générale, d’une pleine capacité juridique pour accomplir tous les actes et opérations ayant un rapport direct ou indirect avec son objet ou qui seraient de nature à faciliter directement ou indirectement, entièrement ou partiellement, la réalisation de cet objet.
- Elle peut s'intéresser par voie d'association, d'apport, de fusion, d'intervention financière ou autrement dans toutes sociétés, associations ou entreprises dont l'objet est identique, analogue ou connexe au sien ou susceptible de favoriser le développement de son entreprise ou de constituer pour elle une source de débouchés.
- Elle peut exercer les fonctions d’administrateur ou liquidateur dans d’autres sociétés.
- La société peut se porter garant ou fournir des sûretés réelles pour des sociétés ou des personnes privées, au sens le plus large.
- Au cas où la prestation de certains actes serait soumise à des conditions préalables d'accès à la profession, la société subordonnera son action, en ce qui concerne la prestation de ces actes, à la réalisation de ces conditions.
Invoicing and payment
Financial year and general meeting
Accounts at the NBBSites & property
Buildings and parcels at the address
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 51522B0624/00N000 | Wallonia | 1,108 m² | 1 · 101 m² | 10.4 m · 3 |